Stocks · News reference

Bionano Genomics Says New York State Department Of Health Approved Optical Genome Mapping Lab Developed Tests At University Of Rochester Medicine For Genetic Disorders, Hematologic Malignancies

Sep 8, 2026, 1:01 PMBenzinga Newsdesk

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Keep reading

BenzingaSep 10, 2026, 1:02 PMBenzinga Newsdesk
Bionano Genomics Subsidiary Says MolDX Issues Proposed LCD For Genome-Wide Molecular Methodologies For Detection Of Copy Number Alterations And Structural Variants In Hematologic Neoplasms
Bionano Laboratories, a wholly-owned subsidiary of Bionano Genomics, Inc. (NASDAQ:BNGO) that offers CLIA-certified laboratory developed test (LDTs), today announced that MolDX, a program that assesses molecular
BNGO
BenzingaAug 10, 2026, 8:50 PMBenzinga Newsdesk
Bionano Genomics Q2 EPS $(0.64) Beats $(0.69) Estimate, Sales $8.171M Beat $7.476M Estimate
BNGO
BenzingaAug 10, 2026, 8:12 PMBenzinga Newsdesk
Bionano Genomics Q2 Sales $8.171M Beat $7.476M Estimate
BNGO